Skip to main content
OpenTrials
Completed

NCT Number: NCT01593566

Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction

Femoral nerve block using 0.25% bupivacaine or 0.5% bupivacaine provides a longer time for analgesia after Anterior Cruciate Ligament (ACL) reconstruction.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, 10700, Thailand

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients scheduled for ACL reconstruction
  • ASA physical status I-II
  • Body weight > or = 50 kg.

Exclusion criteria

  • Patients with redo ACL reconstruction
  • Contraindication to neuraxial block
  • allergy to local anesthetics, sulfa, NSAIDs, morphine, paracetamol
  • Patients with communication problem

Treatment and study plan

0.25% Bupivacaine

Drug

Femoral nerve block using 0.25% versus 0.5% bupivacaine

Other names: marcaine

0.5% bupivacaine

Drug

Femoral nerve block using 0.25% versus 0.5% bupivacaine for analgesia after ACL reconstruction

Other names: marcaine

Primary outcomes

  1. time to first analgesic requirement

    Time frame: 48 hr

Secondary outcomes

  1. pain score scale

    Time frame: 48 hr

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Registry information

Official study title

Femoral Nerve Block Using 0.25% Versus 0.5% Bupivacaine for Analgesia After Arthroscopic Anterior Cruciate Ligament Reconstruction

Acronym: FNB for ACLR

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
May 8, 2012
Registry last updated
Apr 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.